GSTPi-positive tumour microenvironment-associated fibroblasts are significantly associated with GSTPi-negative cancer cells in paired cases of primary invasive breast cancer and axillary lymph node metastases

British Journal of Cancer

Volumn 105, Issue 8, 2011, Pages 1224-1229

  Chaiwun, B ^a   Sukhamwang, N ^a   Trakultivakorn, H ^a   Saha, B ^b,d   Young, L ^c   Tsao Wei, D ^c   Naritoku, W Y ^c   Groshen, S ^c   Taylor, C R ^c   Imam, S A ^b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Anubhav Biotech Ltd   (India)

Author keywords

smooth muscle actin; breast cancer; cancer associated fibroblast; glutathione S transferase Pi; tumour microenvironment

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ENZYME ANTIBODY; GLUTATHIONE TRANSFERASE P1; VIMENTIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; BREAST EPITHELIUM; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MYOEPITHELIUM; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT;

ACTINS; ADULT; AGED; AXILLA; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FIBROBLASTS; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 80053996706     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.352     Document Type: Article

References (38)

1. Arai T, Miyoshi Kim SJ, Akazawa K, Maruyama N, Taguchi T, Tamaki Y, Noguchi S (2008) Association of GSTPi expression with resistance to docetaxel and paclitaxel in human breast cancers. Eur J Surg Oncol 34: 734-738 (Pubitemid 351826869)
2. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377
3. Brockstedt U, Krajinovic M, Richer C, Mathonnet G, Sinnett D, Pfau W, Labuda D (2002) Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myelo-peroxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferase (GSTs). Mutat Res 516: 41-47 (Pubitemid 34415499)
4. Cat B, Stuhlmann D, Steinbrenner H, Alili L, Holtkötter O, Sies H, Brenneisen P (2006) Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J Cell Sci 119: 2727-2738 (Pubitemid 44184009)
5. DeMarzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, Isaacs WB, Nelson WG (2003) Human prostate cancer precursors and pathobiology. Urology 62: 55-62 (Pubitemid 37371890)
6. Desmouliere A, Guyot C, Gabbiani G (2004) The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48: 509-517 (Pubitemid 39360401)
7. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG (1998) Inactivation of glutathione S-transferase pi gene by promotor hyper-methylation in human neoplasia. Cancer Res 58: 4515-4518 (Pubitemid 28480605)
8. Galiè M, Sorrentino C, Montani M, Micossi L, Di Carlo E, D'Antuono T, Calderan L, Marzola P, Benati D, Merigo F, Orlando F, Smorlesi A, Marchini C, Amici A, Sbarbati A (2005) Mammary carcinoma provides highly tumorigenic and invasive reactive stromal cells. Carcinogenesis 26: 1868-1878 (Pubitemid 41631259)
9. Gonzales-Angulo AM, Morales-Vasquez F, Hortobagyi GN (2007) Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608: 1-22
10. Green JA, Robertson LJ, Clark AH (1993) Glutathione S-transferase expression in benign and malignant ovarian tumours. Br J Cancer 68: 235-239 (Pubitemid 23229418)
11. Ide T, Kitajima Y, Miyoshi A, Ohtsuka T, Mitsuno M, Ohtaka K, Koga Y, Miyazaki K (2006) Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway. Int J Cancer 119: 2750-2759 (Pubitemid 44846225)
12. Imam SA, Esteban EF, Chen RS, Cardiff RD, Taylor CR (1993) Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer. Cancer Res 53: 3233-3236 (Pubitemid 23223287)
13. Jhaveri MS, Morrow CS (1998) Methylation-mediated regulation of the glutathione S-transferase pi gene in human breast cancer cells. Gene 210: 1-7 (Pubitemid 28156380)
14. Manshouri T, Estrov Z, Quintás-Cardama A, Burger J, Zhang Y, Livun A, Knez L, Harris D, Creighton CJ, Kantarjian HM, Verstovsek S (2011) Bone marrow stromal-secreted cytokines protect JAK2V617F-mutated cells from the effects of a JAK2 inhibitor. Cancer Res 71: 3831-3840
15. Mehta CR, Patel NR (1993) A network algorithm for performing Fisher's exact test in rXc contingency tables. J Am Stat Assoc 78: 427-434
16. Micke P, Ostman A (2004) Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy. Lung Cancer 45: 163-175
17. Micke P, Ostman A (2005) Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy. Expert Opin Ther Targets 9: 1217-1233 (Pubitemid 41762875)
18. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Bankerjee D (2008) Carcinoma-associated fibroblast-differentiation human mesenchymal stem cells. Cancer Res 68: 4331-4339
19. Montironi R, Mazzucchelli R, Pomante R, Thompson D, Duval da Silva V, Vaught L, Bartels PH (1999) Immunohistochemical expression of p-class glutathione S-transferase in the basal cell layer of benign prostate tissue following chronic treatment with finasteride. J Clin Pathol 52: 350-354 (Pubitemid 29200026)
20. Morrow CS, Diah S, Smitherman PK, Schneider E, Townsend AJ (1998) Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity. Carcinogenesis 19: 109-115 (Pubitemid 28376832)
21. Moskaluk CA, Duray PH, Cowan KH, Linehan M, Merino MJ (1997) Immunohistochemical expression of p-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer 79: 1595-1599 (Pubitemid 27154793)
22. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin Jr EW, de la Chapelle A, Frankel WL (2004) Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23: 7366-7377 (Pubitemid 39382139)
23. Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K, Nogi Y, Inoue S, Takahashi M, Hata T, Muramatsu M (2001) Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res 7: 3097-3105 (Pubitemid 32963830)
24. Parmar A, Marz S, Rushton S, Holzwarth C, Lind K, Kayser S, Döhner K, Peschel C, Oostendorp RA, Götze KS (2011) Stromal niche cells protect early leukemic FLT3-ITD progenitor cells against first génération of FLT3 tyrosine kinase inhibitors. Cancer Res 71: 4696-4706
25. Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL, Platzer P, Eng C (2007) Breast cancer stromal cells with TP53 mutations and nodel metastases. N Engl J Med 357: 2543-2551 (Pubitemid 350294221)
26. Randall BJ, Angus B, Akiba R, Hall A, Cattan AR, Proctor SJ, Jones RA, Horne CH (1990) Glutathione S-transferase (placental) as a marker for transformation in the human cervix uteri: an immunohistochemical study. Br J Cancer 62: 614-618 (Pubitemid 20340575)
27. Saha B, Chaiwun B, Imam SS, Tsao-Wei DD, Groshen S, Naritoku WY, Imam SA (2007) Overexpression of E-cadherin protein in metastatic breast cancer cells in bone. Anticancer Res 27: 3903-3908
28. Sawaki M, Enomoto K, Takahashi H, Nakajima Y, Mori M (1990) Phenotype of preneoplastic and neoplastic liver lesions during spontaneous liver carcinogenesis of LEC rats. Carcinogenesis 11: 1857-1861 (Pubitemid 20331456)
29. Scarff RW, Torloni H (1968) Histological Typing of Breast Tumors (International Histological Classification of Tumours n'2). World Health Organization: Geneva
30. Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L (2001) Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 61: 1320-1326 (Pubitemid 34292550)
31. Su F, Hu X, Jia W, Gong C, Song E, Hamar P (2003) Glutathion S transferase pi indicates chemotherapy resistance in breast cancer. J Surg Res 113: 102-108 (Pubitemid 36999798)
32. Sugimoto T, Takiguchi Y, Kurosu K, Kasahara Y, Tanabe N, Tatsumi K, Hiroshima K, Minamihisamatsu M, Miyamoto T, Kuriyama T (2005) Growth factor-mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small-cell lung cancer. Oncol Rep 14: 823-830
33. Tang Y, Kesavan P, Nakada MT, Yan L (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-depen-dent generation of soluble EMMPRIN. Mol Cancer Res 2: 73-80 (Pubitemid 38250423)
34. Terrier P, Townsend AJ, Coindre JM, Triche TJ, Cowan KH (1990) An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 137: 845-853 (Pubitemid 20337799)
35. Toffoli G, Viel A, Tumiotto L, Giannini F, Volpe R, Quaia M, Boiocchi M (1992) Expression of glutathione-S-transferase-p in human tumours. Eur J Cancer 28a: 1441-1446
36. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR (2002) Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8: 2912-2923 (Pubitemid 35025739)
37. Van Emburgh BO, Hu JJ, Levine EA, Mosley LJ, Case LD, Lin HY, Knight SN, Perrier ND, Rubin P, Sherrill GB, Shaw CS, Carey LA, Sawyer LR, Allen GO, Milikowski C, Willingham MC, Miller MS (2008) Polymorphisms in drug metabolism genes, smoking, and p53 mutation in breast cancer. Mol Carcinog 47: 88-99 (Pubitemid 351231437)
38. Yu ST, Chen TM, Chern JW, Tseng SY, Chen YH (2009) Down regulation of GSTPi expression by tryptanthrin contribution to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis. Anticancer Drugs 20: 382-388